Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-lindau disease: Targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors

Camilo Jimenez, Maria E. Cabanillas, Libero Santarpia, Eric Jonasch, Karen L. Kyle, Elizabeth A. Lano, Surena F. Matin, Rodolfo F. Nunez, Nancy D. Perrier, Alexandria Phan, Thereasa A. Rich, Beejal Shah, Michelle D. Williams, Steven G. Waguespack

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-lindau disease: Targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds